Harmony Biosciences Holdings, Inc. (NasdaqGM:HRMY) announces a share repurchase program. Under the program, the company will repurchase $200 million worth of shares. The repurchase program has no expiration date.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.22 USD | +0.27% | -2.20% | -6.44% |
30/04 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
30/04 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.44% | 171.63Cr | |
+29.98% | 68TCr | |
+32.16% | 59TCr | |
-3.52% | 36TCr | |
+18.59% | 33TCr | |
+4.07% | 28TCr | |
+16.40% | 24TCr | |
+9.45% | 21TCr | |
-9.00% | 20TCr | |
+7.09% | 17TCr |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Harmony Biosciences Holdings, Inc. announces an Equity Buyback for $200 million worth of its shares.